We are live on ! Find out more
PRPH

ProPhase Labs
PRPH

Delisted

PRPH was delisted on the 2nd of January, 2026.

Back to rankings

15 hedge funds and large institutions have $978K invested in ProPhase Labs in 2020 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 1

15% more funds holding

Funds holding: 13 → 15 (+2)

0.01% more ownership

Funds ownership: 0.44% → 0.45% (+0.01%)

1% less capital invested

Capital invested by funds: $989K → $978K (-$11K)

Holders
15
Holders Change
+2
Holders Change %
+15.38%
% of All Funds
0.33%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
4
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$16.7K
2
Renaissance Technologies
Renaissance Technologies
New York
+$4.3K
3
Victory Capital Management
Victory Capital Management
Texas
+$3.37K
4
UBS Group
UBS Group
Switzerland
+$2.04K
5
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$411

Top Sellers

Rank Fund Capital Flow
1
TRCT
Tower Research Capital (TRC)
New York
-$93

PRPH Hedge Fund Activity: Q1 2020 in Review

15 of the 4,546 institutional investors tracked by Wall St. Rank reported a position in ProPhase Labs (PRPH) for Q1 2020, worth a combined $978K — down 1.1% from $989K a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new PRPH positions and 0 closed out — a net gain of 2 holders — while 4 added to existing stakes and 1 trimmed.

The largest buyer was Susquehanna International Group, adding an estimated $16.7K. The largest seller was Tower Research Capital (TRC), cutting an estimated $93.

  • 15 institutional investors held ProPhase Labs (PRPH) as of Q1 2020, up from 13 in Q4 2019.
  • Funds reported $978K of ProPhase Labs stock for Q1 2020, down 1.1% quarter-over-quarter.
  • 2 funds opened new ProPhase Labs positions in Q1 2020 and 0 closed out, a net change of +2 holders.
  • The largest ProPhase Labs buyer in Q1 2020 was Susquehanna International Group, an estimated $16.7K added.
  • The largest ProPhase Labs seller in Q1 2020 was Tower Research Capital (TRC), an estimated $93 sold.

Based on aggregated 13F filings for Q1 2020.